Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 829

1.

Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.

Lai MW, Lin TY, Tsao KC, Huang CG, Hsiao MJ, Liang KH, Yeh CT.

Gastroenterology. 2012 Aug;143(2):400-7. doi: 10.1053/j.gastro.2012.05.002. Epub 2012 May 10.

PMID:
22580098
2.

Minimization of hepatitis B infection by a 25-year universal vaccination program.

Ni YH, Chang MH, Wu JF, Hsu HY, Chen HL, Chen DS.

J Hepatol. 2012 Oct;57(4):730-5. doi: 10.1016/j.jhep.2012.05.021. Epub 2012 Jun 2.

PMID:
22668640
3.

Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.

Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC.

Vaccine. 2012 Jun 8;30(27):4034-9. doi: 10.1016/j.vaccine.2012.04.031. Epub 2012 Apr 22.

PMID:
22531558
4.

Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.

Aghasadeghi MR, Velayati AA, Mamishi S, Nabavi M, Aghakhani A, Bidari-Zerehpoosh F, Haghi Ashtiani MT, Sabeti S, Banifazl M, Azimian-Zavareh F, Motevalli F, Soleymani S, Ramezani A.

Arch Virol. 2016 Dec;161(12):3405-3411. Epub 2016 Sep 9.

PMID:
27613286
5.

Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.

Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, Kao JH, Lin YC, Chen HL, Hsu HY, Chen DS.

Gastroenterology. 2007 Apr;132(4):1287-93. Epub 2007 Feb 25.

PMID:
17433322
6.

The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.

Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ.

Vaccine. 2001 Jul 16;19(28-29):3919-26.

PMID:
11427266
7.
8.

Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.

Sun HY, Ko WC, Tsai JJ, Lee HC, Liu CE, Wong WW, Su SC, Ho MW, Cheng SH, Yang CH, Lin YH, Miao WJ, Sheng WH, Hung CC.

Am J Gastroenterol. 2009 Apr;104(4):877-84. doi: 10.1038/ajg.2008.159. Epub 2009 Mar 3.

PMID:
19259078
9.

Efficacy of the nationwide hepatitis B infant vaccination program in Taiwan.

Chen SM, Kung CM, Yang WJ, Wang HL.

J Clin Virol. 2011 Sep;52(1):11-6. doi: 10.1016/j.jcv.2011.06.012. Epub 2011 Jul 20.

PMID:
21767983
10.

Hepatitis B vaccination in children: the Taiwan experience.

Ni YH, Chen DS.

Pathol Biol (Paris). 2010 Aug;58(4):296-300. doi: 10.1016/j.patbio.2009.11.002. Epub 2010 Jan 29.

PMID:
20116181
11.

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination.

Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS.

Ann Intern Med. 2001 Nov 6;135(9):796-800.

PMID:
11694104
12.

Seropositivity for hepatitis B virus, vaccination coverage, and vaccine response in dentists from Campo Grande, Mato Grosso do Sul, Brazil.

Batista SM, Andreasi MS, Borges AM, Lindenberg AS, Silva AL, Fernandes TD, Pereira EF, Basmage EA, Cardoso DD.

Mem Inst Oswaldo Cruz. 2006 May;101(3):263-7.

13.

Hepatitis B virus markers in anti-HBc only positive individuals.

Weber B, Melchior W, Gehrke R, Doerr HW, Berger A, Rabenau H.

J Med Virol. 2001 Jul;64(3):312-9.

PMID:
11424120
14.

Seroprevalence of hepatitis B virus among adults at high risk for HIV transmission two decades after implementation of nationwide hepatitis B virus vaccination program in Taiwan.

Sun HY, Cheng CY, Lee NY, Yang CJ, Liang SH, Tsai MS, Ko WC, Liu WC, Wu PY, Wu CH, Lin HH, Hung CC.

PLoS One. 2014 Feb 26;9(2):e90194. doi: 10.1371/journal.pone.0090194. eCollection 2014.

15.

Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.

Zhu CL, Liu P, Chen T, Ni Z, Lu LL, Huang F, Lu J, Sun Z, Qu C.

Vaccine. 2011 Oct 13;29(44):7835-41. doi: 10.1016/j.vaccine.2011.07.098. Epub 2011 Aug 2.

PMID:
21816197
16.
17.

Immune status in preschool children born after mass hepatitis B vaccination program in Taiwan.

Lin DB, Wang HM, Lee YL, Ling UP, Changlai SP, Chen CJ.

Vaccine. 1998 Oct;16(17):1683-7.

PMID:
9713947
18.

Seroprevalence of hepatitis B infection in the Turkish population in Northern Cyprus.

Kurugöl Z, Koturoğlu G, Akşit S, Ozacar T; Northern Cyprus Study Team, Kayimbaşoğlu S, Ozbalikçi S, Erçal G, Güllüelli E, Bakkaloğlu F, Doğan E, Garabli H, Erçal H, Mert C.

Turk J Pediatr. 2009 Mar-Apr;51(2):120-6.

PMID:
19480322
19.

Continuing Decrease in Hepatitis B Virus Infection 30 Years After Initiation of Infant Vaccination Program in Taiwan.

Ni YH, Chang MH, Jan CF, Hsu HY, Chen HL, Wu JF, Chen DS.

Clin Gastroenterol Hepatol. 2016 Sep;14(9):1324-30. doi: 10.1016/j.cgh.2016.04.030. Epub 2016 May 4.

PMID:
27155556
20.

Epidemiology of hepatitis B virus infection among young adults in Taiwan, China after public vaccination program.

Chen CC, Yen CH, Wu WY, Hu SW, Chen SC, Bell WR, Lee MC.

Chin Med J (Engl). 2007 Jul 5;120(13):1155-8.

PMID:
17637244

Supplemental Content

Support Center